CTNND1

Catenin delta-1 · O60716 · CTNND1 on Sugi Atlas →

0 patent compounds predicted against CTNND1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CTNND1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer PHASE2ACTIVE_NOT_RECRUITING
Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel PHASE2NOT_YET_RECRUITING
NG2 and DLL3 CAR-T Cells Targeting Melanoma PHASE1/PHASE2RECRUITING
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation PHASE2WITHDRAWN
Mesalazine Effects in Sporadic Colorectal Adenoma Patients PHASE2COMPLETED
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors PHASE1RECRUITING
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia PHASE1COMPLETED
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma PHASE1RECRUITING
Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies PHASE1COMPLETED
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma PHASE1COMPLETED
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study nanCOMPLETED
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors nanNO_LONGER_AVAILABLE
Klotho _ LRP-6 _ Gastric Adenocarcinoma nanUNKNOWN
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer nanCOMPLETED
CTNNB1 Neurodevelopmental Syndrome - Natural History Study nanRECRUITING
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients nanCOMPLETED
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION nanRECRUITING
Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 nanUNKNOWN
Effect of Mechanical Ventilation on Plasma Concentration Level of R-spondin Proteins nanCOMPLETED
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma. nanRECRUITING
Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial nanNOT_YET_RECRUITING
A Study Collecting Health Information to Understand and Prevent Gastric Cancer nanRECRUITING
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers nanRECRUITING
Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation nanCOMPLETED
Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation nanRECRUITING
CTNNA1 Familial Expansion Study nanRECRUITING
is the Sclerostin Marker of Chronic Periodontitis nanCOMPLETED
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury nanUNKNOWN
Eosinophil Induced Remodelling in Asthma nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CTNND1 binder may also engage these)

ProteinNameSimilarity
P30999 1.000 P30999 →
Q9UQB3 0.995 Q9UQB3 →
Q99569 0.992 Q99569 →
O35927 0.988 O35927 →
Q68FH0 0.988 Q68FH0 →
Q95168 0.984 Q95168 →
P39447 0.982 P39447 →
Q61062 0.982 Q61062 →
B1WAP7 0.982 B1WAP7 →
Q9Z0U1 0.981 Q9Z0U1 →
Q0V989 0.980 Q0V989 →
Q07157 0.980 Q07157 →
Q9UDY2 0.980 Q9UDY2 →
Q17GS9 0.980 Q17GS9 →
DVL3 Segment polarity protein dishevelled homolog DVL-3 0.980 landscape →
Q921D9 0.980 Q921D9 →
A0A0G2K2P5 0.979 A0A0G2K2P5 →
B4F7F3 0.979 B4F7F3 →
Q4KUS2 0.979 Q4KUS2 →
P98203 0.979 P98203 →
Q7KW14 0.978 Q7KW14 →
O97758 0.978 O97758 →
Q4V872 0.978 Q4V872 →
Q9H8E8 0.977 Q9H8E8 →
P18824 0.977 P18824 →
Q58A65 0.977 Q58A65 →
O75122 0.977 O75122 →
P70483 0.977 P70483 →
Q7PQ25 0.976 Q7PQ25 →
Q8CID0 0.976 Q8CID0 →